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Abstract
The effectiveness of the system of pharmaceutical supply to the population depends on the proper interaction of the state and 
market mechanisms for regulating the interests of all subjects of the pharmaceutical market for the implementation of the social policy 
of the state regarding the availability of quality and effective medicines for the population. In the context of healthcare reform, the issues 
of assessing the main stages of the development of the pharmaceutical supply system of the population become especially relevant.
Aim. Determination of key, from organizational, economic and social points of view, stages of formation of the domestic system 
of pharmaceutical supply of the population, analysis of the main tendencies of its development in retrospect years.
Materials and methods. The materials of the research were selected by the regulatory acts, the data of the specialized literature, 
certain aspects of activity of subjects of the pharmaceutical market, etc. Methods such as historical, informational-analytical, analyti-
cal-comparative, systemic, logical, hypothetical-deductive and generalization were used.
Results. Based on the conducted research, five stages of the formation of the pharmaceutical supply system have been identified 
and outlined, which differ fundamentally across the range of criteria for analyzing effectiveness in building relationships between the 
state, civil society and the professional community. These stages were elaborated in accordance with the results of the analysis of the 
nature of relations between the authorities and society under the conditions of gradual transition from paternalistic to the elements of the 
patient-oriented model of medical and pharmaceutical services to the population: 
1) 1990–1993; 
2) 1994–2000;
3) 2001–2007; 
4) 2008–2013;
5) from 2014 to the present.
It has been proved that the stages of development of the domestic pharmaceutical supply system depend to a large extent on the
nature of the influence of external environmental factors: changes of political elites in the country, global and internal financial crises, 
changes of priorities of the state development, breaking of social consciousness of the population against the background of political 
crisis, etc. It should be noted that the most important in terms of positive, first of all socio-economic, development characteristics is the 
fourth stage of formation (2008-2013) of the domestic system of pharmaceutical supply of the population. The last period (since 2014) 
is characterized by the existence of a crisis of relations between all subjects in the system of pharmaceutical provision of the population 
against the background of systemic transformations in the state, strengthening of the role of public professional associations and critical 
raising of public expectations from the state regarding the organization of providing affordable medical care to the population. and 
pharmaceutical assistance in the face of mass impoverishment.
Conclusion. The basic stages of the formation of the domestic pharmaceutical supply system are defined and their characteris-
tics are envisaged, which allow to form in the future fundamentally new approaches to building rational, economically speaking, and 
simultaneously socially responsible relations between different subjects in the pharmaceutical market.
Keywords: pharmaceutical supply system, health care, state regulation of pharmaceutical activity, pharmacy establishments, 
civil society.
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1. Introduction
The peculiarity of the functioning of the pharmaceutical supply system in any country is 
due to several factors, among which the following deserve attention. First, the regulated circu-
lation of medicines (drugs) in the pharmaceutical market (FM) emerges as an important socially 
important mechanism, the effective functioning of which enables the exercise of the constitu-
tional right of citizens to preserve the fundamental value in society, namely health and human 
life. Second, FM is a consumer market sector in which market relations between different entities 
operate. Considering the aforementioned, the effective functioning of the system of pharmaceu-
tical supply to the population depends on the proper interaction of the state and market mech-
anisms of regulating the interests of all subjects of the FM for the implementation of the social 
policy of the state regarding the availability of quality and effective drugs for the population. 
Thus, the effective functioning of the FM must ensure that the social and economic interests 
of all its subjects are balanced. The nature of the interaction between the categories of public 
health and the indicators of the level of solvency of citizens depends on the general structure of 
expenditures on pharmaceutical supply of the population, which, in the final analysis, supply and 
demand in the market of medicines, the corresponding structure of FM, sales volumes, assort-
ment of goods, etc.
Despite the market nature of the functioning of various economic entities, the FM is 
increasingly focusing on increasing the social responsibility of the pharmaceutical business 
to society, above all, providing the population with quality, effective and affordable drugs. A 
special place in building this type of relationship in the pharmaceutical supply system belongs 
to public professional organizations and unions. The most effective functioning of the pharma-
ceutical community and professional self-government, which is based on public organizations, 
associations, unions, in cooperation with state structures, should ensure the formation of so-
cially responsible relations in the modern FM in Ukraine. Currently, the country’s health care 
system is at a turning point. The first stages of public relations pharmaceutical reform, which 
began in 2017, demonstrated the depth of those socio-economic problems that have plagued 
the population for many years. Given the high level of public expectations for improving the 
availability of medical and pharmaceutical care, the question of changing the formats of re-
lationships between entities in the FR and in the health care system is emerging as socially 
significant. Against this background, the analysis of the stages of formation of the domestic 
pharmaceutical supply system in order to identify the directions of its effective development is 
relevant and of social importance.
Problems of formation of the system of pharmaceutical supply of the population in terms 
of relations between the state and civil society have been repeatedly researched by scientists. 
Thus, the priorities for reforming the system of state and social regulation in pharmacy were 
studied by Nemchenko A. S., Susharina I. V., Khomenko V. M. [1]; questions of introduction of 
concept of social responsibility in practical pharmacy, approaches to development of social re-
sponsibility during professional training – Gromovik B. P., Tkachenko N. O. [2]; the main stages 
of the formation of social pharmacy in the world and in Ukraine since the 50’s of the twentieth 
century – Kotvitska A. A., Kubareva I. V. [3]; expediency of participation of public pharmaceu-
tical organizations in standardization of processes of pharmaceutical supply of population – Un-
guryan L. M. [4]; questions of social responsibility of pharmaceutical business and directions of 
its regulation in accordance with international standards – Bratishko Yu. S. [5]. Also, the work 
of foreign authors has explored the issue of strengthening the role of pharmaceutical workers and 
public health services, which requires changes in the behavior of both professionals and society – 
Eades C. E., Ferguson J. S., O’Carroll R. E. [6]; pharmacists’ experience in healthcare teams, 
providing patient care systems – Bush P. W., Daniels R. [7]; pharmacists’ involvement in optimal 
drug use, pharmacotherapy management, which reduces overall health care costs – Blouin R. A., 
Adams M. L. [8].
Aim – identification of key, from organizational, economic and social points of view, stages 
of formation of the domestic system of pharmaceutical supply of the population, analysis of the 
main tendencies of its development in retrospect years.
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2. Materials and methods
The subject of the research was the historical processes of development of the national 
health care system and pharmaceutical supply of the population in the context of state formation 
and formation of civil society, and the objects – mechanisms of state regulation of FM of Ukraine 
and market development of relations between different entities in the process of providing the 
population with medical and pharmaceutical assistance, basic approaches in the organization of 
pharmaceutical activity at different stages of formation of the national health care system. The ma-
terials of the study selected regulatory legal acts (RLAs) regulating the organization of provision 
of medical and pharmaceutical services to the population, data of special literature, which outlines 
the main directions of development of the pharmaceutical supply system of the population, certain 
aspects of the activity of subjects of FM and indicators of its development in the dynamics years 
(volume of retail sales and hospital supplies of drugs in monetary and physical terms, level of pro-
vision by pharmacy establishments). In theoretical studies, we have used such methods as historical 
(study of stages of development in chronological sequence), information-analytical (detection of 
common and different between different stages of development), analytical-comparative (search 
for properties of certain objects in comparison with others), systemic (establishing links between 
the elements of the system under study), logical (establishing logical patterns of development), 
hypothetical-deductive (hypothesis and deduction by deduction) and generalization (results of the 
study are summarized).
The system of pharmaceutical supply to the population in the classical definition appears as 
an integral structure, characterized not only by the complexity of the construction, but also by close 
links with the environment [1, 9]. Therefore, a retrospective analysis of the development of the said 
macrostructure of the country was considered by us, above all, in the context of the formation of the 
Ukrainian state (declaration of independence of Ukraine in 1990), the development of civil society 
and changes in the worldviews of people regarding the attitude to “health” as the highest value in 
the humanistic oriented states.
3. Results of the research
Summarizing the results of the theoretical studies, we have identified the following stages 
of development of the system of pharmaceutical supply of the population, outlined the main trends 
and problems. So, in the early 1990s, when Ukraine gained independence, the issue of providing 
drugs to the population was acute. From the planned economy under the Law “On Enterprises in 
Ukraine” of 26.03.1991, the country embarked on the path of its liberalization and introduction of 
market relations in almost all sectors of the economy. In 1992, the decline in our own production of 
drugs was maximum, during this period, Ukraine received $ 280 million worth of drugs at whole-
sale prices, but it was three times less than during the Soviet Union (USSR) period. However, as 
of January 1, 1992, there were 6,413 pharmacies operating in the system of the Ministry of Health 
of Ukraine, most of them located in cities and towns. The population served by one pharmacy in 
average was 7.9 thousand people, which was significantly higher than in Europe [10].
The need for market transformation for all parts of the macroeconomic complex of the state, 
including FM, became relevant, given the regulatory influence of market relations on establishing the 
necessary proportions between the volume of needs of society in certain goods and their production. 
Under the conditions of transition to a market economy in accordance with the Laws of Ukraine 
“On privatization of state property”, “On privatization of small state-owned enterprises (small pri-
vatization)”, adopted in 1992, processes of privatization of pharmaceutical enterprises, demonop-
olization, creation of alternative structures were observed, including non-state ownership, even in 
socially-oriented industries. The spontaneous, irrational opening of pharmacies has begun with the 
simultaneous catastrophic reduction of their number in rural areas due to the unprofitable situation 
for owners, the creation of associations and pharmacy chains: “Arnica”, “Falby”, “Med-Service”, “Zi” 
and others. (1993–1995). There are also the first powerful distribution companies – “Alba” (1993), 
“BaDM” (1994), “Optima Farm” (1994), “BBC-LTD” (1994), “Venta LTD” (1995).
According to the theory of market relations, social protection of the person in the initial 
stages of the formation of relations between capital and labor resources is not a dominant in society. 
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Thus, it was during this period that the centralized system of providing the population with drugs, 
which had existed in the former USSR for several decades, was completely destroyed in Ukraine. 
The state has withdrawn from the fulfilment of the financial obligations declared in the Constitu-
tion of Ukraine regarding the protection of public health. It is at this time that the shadow market, 
the production and circulation of counterfeit drugs, develops, and aggressively advertises biologi-
cally active additives of unknown production. Domestic pharmaceutical manufacturers are on the 
verge of bankruptcy. This stage of market relations is characterized by low level of development 
of pharmaceutical industry enterprises, low physical and socio-economic availability of drugs for 
the population, as well as inefficiency of functioning of state mechanisms of regulation of quality 
of medicines at all stages of their promotion through the distribution network, from import into 
the country to sale to the end consumer pharmacies. Analyzing the data of the specialized litera-
ture, it can be argued that the government at that time did not realize that one of the guarantors of 
Ukraine’s sovereignty was the effective pharmaceutical supply of the population [10, 11]. However, 
despite the systemic crisis in the state, in 1992 the “Comprehensive Program for the Development 
of the Medical, Veterinary and Microbiological Industry, Improving the Supply of the Population 
and Livestock with Medicines, Medical and Veterinary Equipment for 1992–1996” was developed 
and adopted for construction of new and reconstruction of existing enterprises, expansion of the 
range of production of drugs and medical devices. Positive during this period (1992) was also the 
establishment of important institutions, which were subordinate to the Ministry of Health (MOH) 
of Ukraine and had control functions in the sphere of drug trafficking, in particular, the State In-
spectorate for Quality Control of Drugs, the Pharmacological Committee, Pharmacopoeial Com-
mittee, the successors of which still play an important role in the regulation of pharmaceutical 
activity in Ukraine. In 1993, significant changes occurred in the structure of pharmacy manage-
ment. Thus, the State Committee of Ukraine for Medical and Microbiological Industry (SCUMMI) 
and the Ukrainian Association “Ukrpharmacy” were created. Already from this period, it can be 
argued about the gradual revival of the national health care system and pharmaceutical supply of 
the population as an important component of the country’s macroeconomic complex, the effective 
functioning of which creates favourable conditions for social stability and well-being of the popu-
lation. Thus, the first stage of development lasted from 1990 to 1993.
The second stage of development begins in 1994, when the Ukrainian authorities signed 
the Partnership and Cooperation Agreement between Ukraine and the European Community 
and their Member States and declared their desire for European values and standards, but the 
processes of divestiture of pharmacies did not contribute to the stated purpose. According to ex-
perts, at that time, there were no private drugstore chains in any European Union (EU) country 
that actually forced the society into its own understanding of the drug supply process in accor-
dance with its commercial interests. It was at the second stage of the development of the domestic 
pharmaceutical supply system that an unmistakably significant event took place, namely in 1996 
the Law of Ukraine “On Medicines” was voted, according to which it was envisaged to regulate 
by-laws all issues related to drug trafficking in Ukraine. During this period, qualitative structur-
al changes took place on the domestic FM. Thus, in the use of drugs, the share of domestic drugs 
began to increase gradually, but for the vast majority of the population, medicines remained 
almost inaccessible. Therefore, at the state level, the question arises of the development and 
implementation of effective mechanisms to ensure the physical and socio-economic availability 
of medicines for the general population. At that time, part of the physical shortage of drugs was 
satisfied with the efforts of domestic manufacturers, although the level of socio-economic avail-
ability of drugs remained very low. Thus, gradually FM drugs began to be saturated, in the vast 
majority due to drugs from domestic production and generics of Indian and Eastern European 
production. By the end of 1997, drugs were manufactured in Ukraine 60 % more than in 1992. In 
1998, drugs were imported into Ukraine from almost 50 countries [10]. The logical consequence 
of the development of the domestic system of pharmaceutical supply to the population and the 
gradual transition to the implementation of European norms and requirements in the pharmaceu-
tical sector of the economy was the large-scale development and implementation of a series of 
steps, regulating drug trafficking in Ukraine.
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At this stage, the idea of reforming the pharmaceutical health care industry was to create 
a system of providing the population with affordable and quality drugs, as recommended by the 
World Health Organization (WHO) “Focus on the Patient” (1998) [4]. This was an important qual-
itative breakthrough in the state’s vision for the development of the national health care system. 
In the context of the economic crisis of September 1998, the fall of the national currency, 
the growth of competition in the pharmaceutical sector, the decrease in the level of solvency of the 
population, in Ukraine there was a tendency to increase the level of wholesale and retail prices for 
drugs. However, due to the lack of a consistent national drug policy under the slogan of reforming 
the pharmaceutical sector within the Ministry of Health of Ukraine, organizational structures were 
created, with provisions for activities declaring comprehensive functions that could not be put 
into practice in Ukrainian realities (1999-2000 – National agency on quality and safety control of 
food, medicines and medical products). This structure was to combine: production control (until 
now State Committee on Biomedicine Industry), control in the field of drug development, regis-
tration and use (Pharmacological Committee and Committee on Immunobiological Preparations), 
control in the field of implementation (State Inspectorate for Quality Control of drugs). That was 
an attempt to build a centralized model for regulating drug trafficking in Ukraine. However, this 
state structure did not exist for 2 years. By decree of the President of Ukraine dated July 24, 2000, 
No. 918/2000, the activity of the said body was cancelled. Following the elimination of the above-men-
tioned National Agency in 2000, a State Department for Quality Control, Safety and Production of 
Drugs and Medical Devices was formed within the Ministry of Health, despite its functioning in the 
country of the State Inspectorate for Quality Control of Drugs. Thus, at this stage, a foundation was 
laid for the operation of an expanded (multiple) model of drug trafficking on FM. 
The third stage (2001–2007) of the development of the pharmaceutical supply system be-
gins in 2001, when the government took steps to ensure the physical and socio-economic availabil-
ity of drugs to the public. First, the Verkhovna Rada of Ukraine adopted Resolution No. 2564-III 
“On Information of the Cabinet of Ministers of Ukraine on Implementation of the Policy of State 
Regulation of Drugs and Medical Devices”, which defined a program of measures to increase the 
availability of drugs and medical devices for the population, rational use of funds for the purchase 
of drugs, the development of a national list of essential (vital) drugs and medical products, and the 
introduction of a formulated system of medical supply for the population. At the end of 2001, a 
number of important RLAs were adopted that regulate pharmaceutical activity in the country as a 
whole and the circulation of drugs in particular:
– Resolution of the Cabinet of Ministers of Ukraine (CMU) No. 1482 “On Approving the
National List of Essential (Essential) Drugs and Medical Devices”;
– Order of the Ministry of Health of Ukraine No. 479 “On Amendments to the List of Med-
icines of Domestic and Foreign Production that may be Purchased by Health and Medical Institu-
tions Fully or Partially Funded from the State and Local Budgets”;
– Order of the Ministry of Health of Ukraine and the Ministry of Economy and European
Integration of Ukraine No. 480/294 “On Approval of the List of Domestic and Imported Medicines 
and Medical Devices, Prices for which are Subject to State Regulation”.
With the increase of financial stability and growth of the country’s gross domestic product, 
the volume of domestic FM significantly increased during this period. Thus, as of January 1, 2003, 
6620 registered drugs were registered in Ukraine, covering almost all pharmacotherapeutic groups, 
of which 40 % were of domestic production. A large-scale process of step-by-step implementation 
of GMP requirements at such powerful enterprises as “Styrol”, “Darnitsa”, “Farmak”, “Borscha-
govsky HFZ”, “Indar” and others has begun to increase the quality requirements of drugs. On the 
whole, the macroeconomic situation in the Ukrainian FM improved significantly during this peri-
od, with an average annual growth rate of 21 %. Due to the increase in real incomes, the consump-
tion of drugs increases – from $ 23 to $ 48 per person. However, these indicators are much lower 
than the existing indicators in the EU countries at the time (Czech Republic – $ 331, Slovakia – 
$ 254, Poland – $ 154).
An important step towards improving physical and socio-economic accessibility was the 
approval in 2006 of CMU Resolution No. 400 of the “Second Edition of the National List of Ba-
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sic Drugs and Medical Devices”, which already contained 783 international non-proprietary or 
accepted names of active substances [12, 13]. Adopted at the end of 2007, “The Concept for the 
Development of the Pharmaceutical Sector of Healthcare in Ukraine” defined the task of develop-
ing a national policy for setting social priorities in providing the population with drugs, as well as 
implementing international standards (production, clinical, laboratory, distribution, pharmacy and 
other good practices) as the most important components in shaping a modern model of regulation 
of drug trafficking on FM.
With the onset of the global financial and economic crisis (2008), the fourth stage (2008–
2013) of the development of the pharmaceutical supply system for the population began, which 
Ukraine has done quite successfully, building a strong structure within the country’s macroeco-
nomic complex. It should be noted that the beginning of this stage of development of the pharma-
ceutical supply system was characterized by the emergence of negative trends in FM, primarily due 
to its import dependence. Against the background of the gradual rise in drug prices, the Govern-
ment of Ukraine has made it possible to remedy the situation by introducing a number of measures 
aimed at curbing purchase, wholesale, and retail prices. The process of improving the functioning 
of the state system of quality control of medicines also continued. In the event of worsening of 
the crisis phenomena on FM, the signing of the Memorandum on joining, accepting, amending 
and reviewing complaints within the framework of Rules for proper promotion by pharmaceutical 
companies to drug professionals by the representatives of 35 foreign and domestic pharmaceutical 
companies of the Ministry of Health of Ukraine looks positive in the summer of 2008. From this 
period it can be argued that Ukraine has laid the foundations for the implementation of important 
components in building a socially oriented model of the pharmaceutical business [14, 15]. An-
other important document that outlined the scale and irreversibility of changes in this direction 
was the Code of Ethics for Pharmaceutical Workers of Ukraine, which was adopted in September 
2010 at the VII National Congress of Pharmacists of Ukraine [16]. This document for the first 
time in the history of domestic pharmacy declared a professionally and socially oriented model 
of behavior of pharmacy professionals in society in accordance with the modern paradigm of 
transformation of pharmaceutical assistance and services in the direction of increasing the social 
responsibility of pharmacies.
Consistency in the implementation of state policy in the system of pharmaceutical sup-
ply to the population was demonstrated by the fact that in 2010 by the order of the Ministry of 
Health of Ukraine No. 769, the “Concept of development of the pharmaceutical sector of health 
care of Ukraine for 2011–2020” was adopted, which was developed on behalf of the CMU in 
order to ensure the availability of high quality drugs, medical devices and medical equipment 
for the population [17]. improving the physical and socio-economic availability of drugs with 
proven efficacy, safety and quality through the use of drugs in accordance with drug forms, pro-
tocols and treatment standards, the introduction of state pricing regulations, and international 
standards for quality assurance of products and medical and pharmaceutical services. It should 
be noted that despite the import dependence of domestic FM and the consequences of the finan-
cial crisis in 2010–2012 in Ukraine, the physical availability of drugs has gradually increased. 
From a socio-economic point of view, the fact is that the domestic industry is showing a steady 
tendency for overproduction, which contributed to the gradual development of drug exports, 
especially to the countries of the former USSR. In order to solve the problem of low socio-eco-
nomic availability of drugs, one of the perspective directions for the development of the system 
of pharmaceutical supply to the population is the introduction by the Government of the country 
of introduction of mechanisms for reimbursement of expenditures for drugs, a formulary system 
at all levels of provision of medical and pharmaceutical assistance and a model of compulsory 
state medical insurance [18].
Due to the transition of many quantitative positive changes to qualitative ones in 2011, 
Ukraine, represented by the State Drugs Service of Ukraine, became a full member of the Inter-
national Pharmaceutical Inspection Co-operation Scheme (PIC/S). It should be noted that today 
from the list of countries of the former USSR, except for the Baltic states, which are members of 
the European Union, only Ukraine is part of the mentioned influential international organization. 
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For the first time on domestic FM, in order to increase the economic availability of drugs, in 
April 2012 the Cabinet of Ministers adopted Resolution No. 340 “On the implementation of a pilot 
project on the introduction of state regulation of the prices of drugs for the treatment of persons 
with hypertension”, which introduced the state regulation of the prices for drugs for that group. 
patients by setting the limit of wholesale prices for such drugs and working out a mechanism for 
partial reimbursement of their value. The implementation of this document was aimed at increasing 
the availability of drugs for low-income and socially unprotected patients with hypertension.
As a result of the Ukrainian government’s earlier stated intention to implement a set of in-
ternational good practice standards, primarily GMP, the number of licensees decreased from 151 to 
111, respectively, in the period 2009-2013. At the same time, against the background of a decrease 
in the number of domestic producers, the volume of industrial production of products in monetary 
terms increased by almost 117 % and exports – by 118 %. It should be noted that the share (%) of 
drugs produced by domestic production in total volume on domestic FM increased from 25.3 % in 
2009 to 35.5 % in 2013 [19, 20]. Systematizing the results of the study, it can be argued that 2013 is 
one of the most successful periods in the development of Ukraine’s pharmaceutical sector. 
With the advent of the political, financial and socio-economic crisis in 2014, the fifth stage 
of the development of the pharmaceutical supply system for the population, which has been signifi-
cantly influenced by external factors, begins. In 2014, the country experienced dramatic changes in 
virtually all areas of public relations. The systemic crisis in the country, the loss of territories due 
to the start of hostilities in the east of the country and the annexation of the Autonomous Republic 
of Crimea have led to significant structural changes in the system of pharmaceutical supply to the 
population. In 2014, as a result of fundamental changes in the exchange rate policy of the National 
Bank of Ukraine and as a result of the uncontrolled devaluation of the hryvnia (from February to 
August, more than 70 %), there was a significant decrease in the consumption of drugs and medical 
devices. This period was characterized by a decrease in sales volumes, both in US dollars and in 
kind. In 2015, the lowest FM drug volume was recorded in US dollars (US $ 2.28 billion) (Fig. 1). 
In terms of in-kind drug sales, there was also a decline from 1.4 billion packs in 2012 to a minimum 
in 2015 (1.1 billion packs) and a gradual increase further to 1.3 in 2018 [21]. 
Fig. 1. Dynamics of retail sales and hospital supply of drugs in monetary terms, indicating 
the share of each of the segments
The increase (38.0 %) of hryvnia sales, which was observed in 2015, was due to the deval-
uation of the national currency. Amid the financial crisis, weakening of the executive branch, lack 
of a systematic approach to managing the industry, there was a sharp rise in drug prices and a 
sharp decline in drug consumption. It became very difficult to control the situation on FM, so the 
government introduced mechanisms of direct government regulation over a wide range of phar-
maceutical activities, restrictions, differentiation of retail allowances, the declaration of wholesale 
and selling prices for drugs purchased for budgetary funds, the introduction of a 7 % value added 
tax on drugs (April 2014), changing the rules for centralized drug procurement [22]. Under these 
conditions, the need for deregulation of the FM retail chain has become increasingly discussed in 
the pharmaceutical community. 
It is well known that increasing regulatory pressure on FM subjects always automatically 
entails additional costs for businesses, with the direct consequence of reducing the socio-eco-
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nomic and further physical availability of drugs [23–25]. Significant structural shifts in drug use 
have occurred during the fifth period of the pharmaceutical supply system’s development. Thus, 
with the gradual stabilization of the economic situation (2015–2016) in the country, Ukrainian 
consumers have increasingly preferred foreign-made drugs. An important event in the develop-
ment of the national system of pharmaceutical supply to the population was the implementation 
of the government program “Available medicines” for persons suffering from cardiovascular 
diseases, type II diabetes, bronchial asthma since April 2017. The Affordable Care program was 
implemented against the background of reforming the entire healthcare system and implement-
ing e-Health.
An important place in the development of the system of pharmaceutical supply to the popu-
lation in the direction of implementation of modern norms and requirements was taken by the Cab-
inet of Ministers of Ukraine №1022 of December 5, 2018 “State strategy for the implementation 
of the state policy of providing the population with medicines for the period up to 2025” [17]. The 
document outlined policy commitments to ensure the availability and rational use of effective and 
safe drugs. First of all, it concerned the socio-economic availability of drugs, as physical availabil-
ity was provided by a sufficient number of pharmacies in Ukraine. For example, as of January 1, 
2019, 1 pharmacy serves an average of 2,044 citizens (Fig. 2) [21]. 
Fig. 2. Dynamics of the number of different types of shopping unit on FM Ukraine
Systematizing the assets of the fifth stage of development of the domestic system of pharma-
ceutical supply to the population, it is necessary to determine the following characteristics:
– introduction of e-Health elements in the organization of providing medical and pharma-
ceutical assistance to patients, in particular servicing the population by electronic prescriptions at 
the primary health care unit;
– the adoption in 2017 of a new National List of Essential Drugs (427 INN), which oc-
cupies a dominant position in the FM regulatory space and complies with WHO requirements 
(20thWHOEML (March 2017);
– the operation of the Government’s Affordable Care Program;
– changes in the order of centralized procurement of drugs used to resolve socially signifi-
cant issues through “ProZorro” and international agencies;
– consolidating the efforts of the professional community to enhance the influence of pro-
fessional associations on the processes of organizing the provision of pharmaceutical assistance to 
the population and regulating pharmaceutical activity in the country;
– increasing the level of social responsibility of the pharmaceutical business and the forma-
tion of an updated model of capital-society relations on FM;
– implementation of European rules on the registration of drugs (simplified registration and
mutual recognition procedure).
Thus, it can be argued that, despite the complexity of development, the domestic pharma-
ceutical supply system has shown, from one point of view, a significant dependence on external en-
vironmental factors, and on the other, significant development potential and the ability to respond 
quickly to numerous changes in factors of influence. 
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4. Discussion of the results
On the basis of generalization of the processed material, we have identified the main five 
stages of the formation of the system of pharmaceutical supply of the population in terms of the 
formation of relationships between authorities and society from paternalistic to the emergence of 
elements of the patient-oriented model:
– 1990–1993 – chaotic development of FM and gradual emergence of market relations in the 
organization of provision of pharmaceutical services to the population, low level of efficiency of 
state regulation of pharmaceutical activity in its various aspects and directions;
– 1994–2000 – laying the legal, organizational, economic and administrative bases for the 
construction of a European-oriented model of pharmaceutical activity, such as an expanded (mul-
tiple) model of regulation of drug trafficking on FM;
– 2001–2007 – further development of a European-oriented model of pharmaceutical activi-
ty (gradual implementation of a set of good practices, first of all production) and an expanded (mul-
tiple) model of regulation of drug trafficking on FM against the background of gradual strengthen-
ing of state regulation of pharmaceutical activity at all stages of the promotion of drugs network;
– 2008–2013 – the emergence and gradual development of socially oriented models of rela-
tions between different subjects of pharmaceutical relations, subject to the declaration by the state of 
European standards and requirements for the organization of accessible and effective medical and 
pharmaceutical care in accordance with the requirements of the WHO National Medicinal Policy;
– from 2014 to the present – crisis of relations between all subjects of relations in the system 
of pharmaceutical supply of the population against the background of systemic transformations in 
the state, strengthening of the role of public professional associations and critical raising of public 
expectations from the state regarding the organization of providing affordable medical care to the 
population and pharmaceutical assistance in the face of mass impoverishment.
The identified main stages of the formation of the pharmaceutical supply system in Ukraine 
and their characteristics allow to form in the future fundamentally new approaches to building ra-
tional, economically speaking, and at the same time socially responsible relations between different 
subjects on FM.
5. Conclusions
1. Based on our research, we have identified and outlined five stages in the development 
of the pharmaceutical supply system, which differ fundamentally across the spectrum of perfor-
mance analysis criteria in building relationships between the state, civil society and the profes-
sional community.
2. It is proved that the stages of development of the domestic pharmaceutical supply system 
depend to a large extent on the nature of influence of external environmental factors: changes of 
political elites in the country, global and internal financial crises, changes of priorities of the state 
development, breaking of social consciousness of the population against the background of political 
crisis, etc.
3. It should be noted that the most important of the positive, first of all socio-economic, 
characteristics of development is the fourth stage of formation (2008–2013) of the domestic system 
of pharmaceutical supply of the population.
4. A promising direction for further research will be the development of theoretical and 
applied approaches to improving socially-oriented relations between different subjects of FM on 
the path from a paternalistic to a patient-oriented model of development of national health care in 
general and the system of pharmaceutical supply to the population in particular.
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